The benefits of niacin in atherosclerosis (Q31729365)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	The benefits of niacin in atherosclerosis	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

review article

1 reference

stated in

Europe PubMed Central

title

The benefits of niacin in atherosclerosis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

main subject

atherosclerosis

1 reference

based on heuristic

inferred from title

niacinamide

1 reference

based on heuristic

inferred from title

author name string

Tavintharan S

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

Kashyap ML

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

publication date

1 January 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

published in

Current Atherosclerosis Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

page(s)

74-82

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

cites work

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11883-001-0014-Y

retrieved

21 January 2018

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11883-001-0014-Y

retrieved

21 January 2018

Effect of a combination of gemfibrozil and niacin on lipid levels

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11883-001-0014-Y

retrieved

21 January 2018

Combination therapy with low-dose lovastatin and niacin is as effective as higher-dose lovastatin.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanistic studies of high-density lipoproteins

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the Effect of Nicotinic Acid on Catecholamine Stimulated Lipolysis in Adipose Tissue in Vitro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of an extended-release niacin (Niaspan): a long-term study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvastatin with and without niacin for hypercholesterolemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of nicotinic acid on serum cholesterol in man.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nicotinic acid-induced fulminant hepatic failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic toxicity of unmodified and time-release preparations of niacin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of crystalline nicotinic acid-induced hepatic dysfunction on serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE EFFECT OF NICOTINIC ACID IN DIABETES MELLITUS

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clofibrate and niacin in coronary heart disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin B-6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacin's hypolipidemic effects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Niacin treatment increases plasma homocyst(e)ine levels

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoprotein Lp(a) excess and coronary heart disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11123852

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11883-001-0014-Y

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

Dimensions Publication ID

1009807986

0 references

PubMed publication ID

11123852

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11123852

retrieved

3 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31729365&oldid=2195117125"